Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
A Z-Pak is a 5-day course of azithromycin, an antibiotic prescribed for certain bacterial infections such as bronchitis, community-acquired pneumonia, sinusitis, strep throat, ear infections, and some sexually transmitted infections like chlamydia. It does not work against viral illnesses like colds, flu, or COVID-19, and taking it unnecessarily can fuel antibiotic resistance and side effects including nausea, diarrhea, and rare heart rhythm changes. Dosing, drug interactions, and whether azithromycin is even the right choice depend on the specific infection and your health history, so there are several important details to consider below before assuming a Z-Pak is the answer. Because many conditions that feel like a "sinus infection" or "chest cold" are viral and resolve without antibiotics, understanding what is actually causing your symptoms is the fastest way to get the right treatment instead of the wrong prescription. Take a free, instant, online symptom check to see which conditions match your symptoms and what steps to take next.
Last reviewed for medical accuracy: 09/24/2026
A Z-Pak is a commonly prescribed form of azithromycin, an antibiotic in the macrolide class. You’ve probably heard healthcare providers mention “azithromycin Z pack” when talking about bacterial infections. This guide will explain what a Z-Pak treats, how it works, and essential safety information—all in clear, straightforward language.
Azithromycin stops bacteria from growing by interfering with their protein production. Specifically, it binds to bacterial ribosomes—tiny structures that read genetic instructions—so the bacteria can’t multiply or repair themselves. Over time, your immune system finishes clearing the weakened bacteria.
Key points:
Azithromycin Z-Packs are approved to treat a variety of bacterial infections, including:
Important: Azithromycin treats only bacterial infections. It is not effective against viruses such as the common cold or flu.
Most adults follow this schedule:
Children’s dosing is weight-based. Always follow your healthcare provider’s instructions exactly.
Most people tolerate azithromycin well. Common side effects include:
Less common but serious side effects (seek immediate medical attention):
If you experience chest pain, fainting, or signs of severe allergic reaction, call 911 or go to the nearest emergency department.
Before starting an azithromycin Z-Pak, tell your doctor if you:
Your healthcare provider will assess for potential interactions and adjust your treatment accordingly.
While a Z-Pak often resolves mild to moderate infections, watch for warning signs that require prompt evaluation:
For a free, online symptom check, using the doctor approved Ubie Symptom Checker you can get personalized guidance and determine if you need to see a healthcare professional.
This information is based on established clinical guidelines and credible medical sources. If you have persistent symptoms or concerns about your treatment, speak to a doctor to ensure safe and effective care.
(References)
* Varghese GM, Dayanand D, Gunasekaran K, Kundu D, Wyawahare M, Sharma N, Chaudhry D, Mahajan SK, Saravu K, Aruldhas BW, Mathew BS, Nair RG, Newbigging N, Mathew A, Abhilash KPP, Biswal M, Prasad AH, Zachariah A, Iyadurai R, Hansdak SG, Sathyendra S, Sudarsanam TD, Prakash JAJ, Manesh A, Mohan A, Tarning J, Blacksell SD, Peerawaranun P, Waithira N, Mukaka M, Cheah PY, Peter JV, Abraham OC, Day NPJ, INTREST Trial Investigators. Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus. N Engl J Med. 2023 Mar 2;388(9):792-803. doi: 10.1056/NEJMoa2208449. PMID: 36856615; PMCID: PMC7614458.
* Bizjak ED, Haug MT 3rd, Schilz RJ, Sarodia BD, Dresing JM. Intravenous azithromycin-induced ototoxicity. Pharmacotherapy. 1999 Feb;19(2):245-8. doi: 10.1592/phco.19.3.245.30930. PMID: 10030778.
* O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IM, Beidi D, Galo N, Harouna N, Karamba AM, Mahamadou S, Abarchi M, Ibrahim A, Lebas E, Peterson B, Liu Z, Le V, Colby E, Doan T, Keenan JD, Oldenburg CE, Porco TC, Arnold BF, Lietman TM, AVENIR study group. Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial. N Engl J Med. 2024 Aug 22;391(8):699-709. doi: 10.1056/NEJMoa2312093. PMID: 39167806.
* Lavoie G, Howell I, Melhorn J, Borg C, Bermejo-Sanchez L, Seymour J, Jabeen MF, Fries A, Hynes G, Pavord ID, Petousi N, Hinks TS. Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment. Thorax. 2025 Jan 17;80(2):113-116. doi: 10.1136/thorax-2024-221977. Epub 2025 Jan 17. PMID: 39694544; PMCID: PMC11877106.
* Irshad M, Syed AW, Shahid MW, Naeem U, Mirza M, Naeem S. Comparative Effects of Azithromycin and Probiotics for Treatment of Acne Vulgaris. J Coll Physicians Surg Pak. 2023 May;33(5):516-520. doi: 10.29271/jcpsp.2023.05.516. PMID: 37190684.
* Odeyemi YE, Tekin A, Schanz CC, Schreier DJ, Cole K, Gajic O, Barreto EF. Comparative Effectiveness of Azithromycin Versus Doxycycline in Hospitalized Patients With Community-Acquired Pneumonia Treated With Beta-Lactams: A Multicenter Matched Cohort Study. Clin Infect Dis. 2026 Apr 30;82(4):639-647. doi: 10.1093/cid/ciaf252. PMID: 40378193; PMCID: PMC13284779.
* RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021 Feb 13;397(10274):605-612. doi: 10.1016/S0140-6736(21)00149-5. Epub 2021 Feb 2. PMID: 33545096; PMCID: PMC7884931.
* Gedikli MA, Tuzun B, Aktas A, Sayin K, Ataseven H. Are clarithromycin, azithromycin and their analogues effective in the treatment of COVID19? Bratisl Lek Listy. 2021;122(2):101-110. doi: 10.4149/BLL_2021_015. PMID: 33502877.
* Uzun S, Djamin RS, Kluytmans JA, Mulder PG, van't Veer NE, Ermens AA, Pelle AJ, Hoogsteden HC, Aerts JG, van der Eerden MM. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2014 May;2(5):361-8. doi: 10.1016/S2213-2600(14)70019-0. Epub 2014 Apr 15. PMID: 24746000.
* Chotsiri P, Tarning J, Hoglund RM, Watson JA, White NJ. Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers. Clin Pharmacol Ther. 2022 Oct;112(4):824-835. doi: 10.1002/cpt.2665. Epub 2022 Jun 22. PMID: 35598114; PMCID: PMC9540484.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.